R&D Drug discovery has a human biology problem The current opportunity lies in optimising existing discovery methodologies by generating more predictive, reproducible human data.
R&D Go north: Life sciences excellence shines bright in Sweden Gothenburg is Sweden's fastest-growing and second largest city region and one of Europe's leading innovation regions.
R&D Purespring on nephrology & gene therapy in kidney disease Purespring CEO Haseeb Ahmad discusses transforming the treatment of kidney disease, an area of enormous unmet need, and the company's gene therapy.
R&D Sponsored What European Commission marketing authorisation of a teripa... Biosimilars can help support broader patient access while contributing to the long-term sustainability of healthcare systems.
R&D Why critical-care injectables are among the hardest medicine... When hospitals in the United States began delaying elective procedures in 2024 over a shortage of intravenous saline solutions, it exposed a structural vulnerability that rarely makes headl
R&D The future of Oxford: Science, technology, and collaboration In conversation with Professor Lady Sue Black and Simon Ruck about Oxford North, from opening to today.
News ESMO26: Zai and Ideaya showcase DLL3 drugs in lung cancer Two drugs hoping to muscle in on Amgen's first-to-market DLL3-targeting drug Imdelltra – from Zai Lab and Ideaya – have new trial readouts at ESMO.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
